chr10-71323057-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBS1BS2
The NM_018344.6(SLC29A3):c.300+3A>G variant causes a splice region, intron change. The variant allele was found at a frequency of 0.00191 in 1,612,724 control chromosomes in the GnomAD database, including 61 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.011 ( 30 hom., cov: 34)
Exomes 𝑓: 0.00099 ( 31 hom. )
Consequence
SLC29A3
NM_018344.6 splice_region, intron
NM_018344.6 splice_region, intron
Scores
2
Splicing: ADA: 0.8215
2
Clinical Significance
Conservation
PhyloP100: 4.20
Genes affected
SLC29A3 (HGNC:23096): (solute carrier family 29 member 3) This gene encodes a nucleoside transporter. The encoded protein plays a role in cellular uptake of nucleosides, nucleobases, and their related analogs. Mutations in this gene have been associated with H syndrome, which is characterized by cutaneous hyperpigmentation and hypertrichosis, hepatosplenomegaly, heart anomalies, and hypogonadism. A related disorder, PHID (pigmented hypertrichosis with insulin-dependent diabetes mellitus), has also been associated with mutations at this locus. Alternatively spliced transcript variants have been described.[provided by RefSeq, Mar 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -18 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.38).
BP6
Variant 10-71323057-A-G is Benign according to our data. Variant chr10-71323057-A-G is described in ClinVar as [Benign]. Clinvar id is 300357.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-71323057-A-G is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0107 (1637/152362) while in subpopulation AFR AF= 0.0378 (1571/41588). AF 95% confidence interval is 0.0362. There are 30 homozygotes in gnomad4. There are 754 alleles in male gnomad4 subpopulation. Median coverage is 34. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 30 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC29A3 | NM_018344.6 | c.300+3A>G | splice_region_variant, intron_variant | ENST00000373189.6 | NP_060814.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC29A3 | ENST00000373189.6 | c.300+3A>G | splice_region_variant, intron_variant | 1 | NM_018344.6 | ENSP00000362285.5 |
Frequencies
GnomAD3 genomes AF: 0.0107 AC: 1635AN: 152244Hom.: 30 Cov.: 34
GnomAD3 genomes
AF:
AC:
1635
AN:
152244
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00261 AC: 649AN: 248240Hom.: 13 AF XY: 0.00181 AC XY: 244AN XY: 134512
GnomAD3 exomes
AF:
AC:
649
AN:
248240
Hom.:
AF XY:
AC XY:
244
AN XY:
134512
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000988 AC: 1443AN: 1460362Hom.: 31 Cov.: 35 AF XY: 0.000796 AC XY: 578AN XY: 726486
GnomAD4 exome
AF:
AC:
1443
AN:
1460362
Hom.:
Cov.:
35
AF XY:
AC XY:
578
AN XY:
726486
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0107 AC: 1637AN: 152362Hom.: 30 Cov.: 34 AF XY: 0.0101 AC XY: 754AN XY: 74514
GnomAD4 genome
AF:
AC:
1637
AN:
152362
Hom.:
Cov.:
34
AF XY:
AC XY:
754
AN XY:
74514
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
H syndrome Benign:2
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 28, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at